{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:31:27Z","timestamp":1791297087217,"version":"4.1.0"},"reference-count":46,"publisher":"Japan Atherosclerosis Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2009]]},"DOI":"10.5551\/jat.2642","type":"journal-article","created":{"date-parts":[[2011,6,16]],"date-time":"2011-06-16T13:45:38Z","timestamp":1308231938000},"page":"878-887","source":"Crossref","is-referenced-by-count":56,"title":["Assessment of an ELISA Kit for Platelet-Derived Microparticles by Joint Research at Many Institutes in Japan"],"prefix":"10.5551","volume":"16","author":[{"given":"Shosaku","family":"Nomura","sequence":"first","affiliation":[{"name":"Division of Hematology, Kishiwada City Hospital."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Shouzu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Saiseikai Izuo Hospital."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsushi","family":"Taomoto","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Ohnishi Neurological Center."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Togane","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Toho University Omori Medical Center."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Goto","sequence":"additional","affiliation":[{"name":"Department of Medicine, Tokai University School of Medicine."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Ozaki","sequence":"additional","affiliation":[{"name":"Department of Clinical and Laboratory Medicine, Faculty of Medicine, University of Yamanashi."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Uchiyama","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tokyo Women's Medical University."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, School of Medicine, Keio University."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Nomura S, Ozaki Y, Ikeda Y: Function and role of microparticles in various clinical settings. Thromb Res, 2008; 123: 8-23","DOI":"10.1016\/j.thromres.2008.06.006"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Morel O, Toti F, Hugel B, Bakouboula B, Camoin-Jau L, Dignat-George F, Freyssinet JM: Procoagulant microparticles: disrupting the vascular homeostasis equation? Arterioscler Thromb Vasc Biol, 2006; 26: 2594-2604","DOI":"10.1161\/01.ATV.0000246775.14471.26"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Matsumoto N, Nomura S, Kamihata H, Kimura Y, Iwasaka T: Increased level of oxidized LDL-dependent monocyte-derived microparticles in acute coronary syndrome. Thromb Haemost, 2004; 91: 146-154","DOI":"10.1160\/TH03-04-0247"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Diamant M, Tushuizen ME, Abid-Hussein MN, Hau CM, B&ouml;ing AN, Sturk A, Nieuwland R: Simvastatin-induced endothelial cell detachment and microparticle release are prenylation dependent. Thromb Haemost, 2008; 100: 489-497","DOI":"10.1160\/TH07-12-0760"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Nomura S: Function and clinical significance of platelet-derived microparticles. Int J Hematol, 2001; 74: 397-404","DOI":"10.1007\/BF02982082"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Nomura S, Komiyama Y, Miyake T, Miyazaki Y, Kido H, Suzuki M, Kagawa H, Yanabu M, Takahashi H, Fukuhara S: Amyloid &beta;-protein precursor-rich platelet microparticles in thrombotic disease. Thromb Haemost, 1994; 72: 519-522","DOI":"10.1055\/s-0038-1648906"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Miyazaki Y, Nomura S, Miyake T, Kagawa H, Kitada C, Taniuchi H, Komiyama Y, Fujimura Y, Ikeda Y, Fukuhara S: High shear stress can intiate both platelet aggregation and shedding of procoagulant containing microparticles. Blood, 1996; 88: 3456-3464","DOI":"10.1182\/blood.V88.9.3456.bloodjournal8893456"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Ray DM, Spineilli SL, Pollock SJ, Murant TI, O'Brien JJ, Blumberg N, Francis CW, Taubman MB, Phipps RP: Peroxisome proliferator-activated receptor &gamma; and retinoid X receptor transcription factors are released from activated human platelets and shed in microparticles. Thromb Haemost, 2008; 99: 86-95","DOI":"10.1160\/TH07-05-0328"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Sinauridze EI, Kireev DA, Popenko NY, Pichugin AV, Panteleev MA, Krymskaya OV, Ataullakhanov FI: Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets. Thromb Haemost, 2007; 97: 425-434","DOI":"10.1160\/TH06-06-0313"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Nomura S, Inami N, Iwasaka T: Differences in functional roles between activated platelets and platelet-derived microparticles. Thromb Haemost, 2007; 98: 1143-1144","DOI":"10.1160\/TH07-03-0217"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Robert S, Poncelet P, Lacroix R, Arnaudo L, Giraudo L, Hauchard A, Sampol J, Dignat-George F: Standardization of platelet-derived microparticle counting using calibrated beads and cytomics FC 500 routine flow cytometer: a first step towards multicenter studies? J Thromb Haemost, 2009; 7: 190-197","DOI":"10.1111\/j.1538-7836.2008.03200.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Osumi K, Ozeki Y, Saito S, Nagamura Y, Ito H, Kimura Y, Ogura H, Nomura S: Development and assessment of enzyme immunoassay for platelet-derived microparticles. Thromb Haemost, 2001; 85: 326-330","DOI":"10.1055\/s-0037-1615688"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Nomura S, Uehata S, Saito S, Osumi K, Ozeki Y, Kimura Y: Enzyme immunoassay detection of platelet-derived microparticles and RANTES in acute coronary syndrome. Thromb Haemost 2003; 89: 506-512","DOI":"10.1055\/s-0037-1613381"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Ueba T, Haze T, Sugiyama M, Higuchi M, Asayama H, Karitani Y, Nishikawa T, Yamashita K, Nagami S, Nakayama T, Kanatani K, Nomura S: Level, distribution and correlates of platelet-derived microparticles in healthy individuals with special reference to the metabolic syndrome. Thromb Haemost, 2008; 100: 280-285","DOI":"10.1160\/TH07-11-0668"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Kanatani K, Nomura S: A method for measurement of platelet-derived microparticles. Jpn J Thromb Hemostas, 2007; 18: 653-659","DOI":"10.2491\/jjsth.18.653"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Nomura S, Suzuki M, Katsura K, Xie GL. Miyazaki Y, Miyake T, Kido H, Kagawa H, Fukuhara S: Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus. Atherosclerosis, 1995; 116: 235-240","DOI":"10.1016\/0021-9150(95)05551-7"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Nomura S, Shouzu A, Omoto S, Hayakawa T, Kagawa H, Nishikawa M, Inada M, FujimuraY, Ikeda Y, Fukuhara S: Effect of cilostazol on soluble adhesion molecules and platelet-derived microparticles in patients with diabetes. Thromb Haemost, 1998; 80: 388-392","DOI":"10.1055\/s-0037-1615217"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Omoto S, Nomura S, Shouzu A, Hayakawa T, Shimizu H, Miyake Y, Yonemoto T, Nishikawa M, Fukuhara S, Inada M: Significance of platelet-derived microparticles and activated platelets in diabetic nephropathy. Nephron, 1999; 81: 271-277","DOI":"10.1159\/000045292"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Nomura S, Shouzu A, Omoto S, Nishikawa M, Fukuhara S: Significance of chemokines and activated platelets in patients with diabetes. Clin Exp Immunol 2000; 121: 437-443","DOI":"10.1046\/j.1365-2249.2000.01324.x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Nomura S, Kanazawa S, Fukuhara S: Effects of eicosapentaenoic acid on platelet activation markers and cell adhesion molecules in hyperlipidemic patients with type 2 diabetes mellitus. J Diabet Complicat, 2003; 17: 153-159","DOI":"10.1016\/S1056-8727(02)00172-1"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Tan KT, Tayebjee MH, Lim HS, Lip GY: Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels. Diabet Med, 2005; 22: 1657-1662","DOI":"10.1111\/j.1464-5491.2005.01707.x"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Ogata N, Imaizumi M, Nomura S, Shouzu A, Arichi M, Matsuoka M, Matsumura M: Increased levels of platelet-derived microparticles in patients with diabetic retinopathy. Diabet Res Clin Pract, 2005; 68: 193-201","DOI":"10.1016\/j.diabres.2004.10.010"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Meigs JB, Hu FB, Rifai N, Manson JE: Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA, 2004; 291: 1978-1986","DOI":"10.1001\/jama.291.16.1978"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Nomura S, Shouzu A, Omoto S, Nishikawa M, Iwasaka T: 5-HT2A receptor antagonists increases circulating adiponectin inpatients with type 2 diabetes. Blood Coagul Fiblinolysis, 2005; 16: 423-428","DOI":"10.1097\/01.mbc.0000176197.48134.08"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Lee YJ, Jy W, Horstman LL, Janania J, Reyes Y, Kelley RE, Ahn YS: Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementias. Thromb Res, 1993; 72: 295-304","DOI":"10.1016\/0049-3848(93)90138-E"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Tan KT, Lip GY: Platelet microparticles and platelet adhesion: therapeutic implications for the prevention and treatment of stroke. Curr Treat Options Cardiovasc Med, 2006; 8: 251-258","DOI":"10.1007\/s11936-006-0019-5"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Gawaz M, Neumann FJ, Ott I, Schiessler A, Schomig A: Platelet function in acute myocardial infarction treated with direct angioplasty. Circulation, 1996; 93: 229-237","DOI":"10.1161\/01.CIR.93.2.229"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Van der Zee PM, Bir&oacute; E, Ko Y, de Winter RJ, Hack CE, Sturk A, Nieuwland: P-selectin- and CD63-exposing platelet microparticles refrect platelet activation in peripheral arterial disease and myocardial infarction. Clin Chem, 2006; 52: 657-664","DOI":"10.1373\/clinchem.2005.057414"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Namba M, Tanaka A, Shimada K, Ozeki Y, Uehata S, Sakamoto T, Nishida Y, Nomura S, Yoshikawa J: Circulating platelet-derived microparticles are associated with atherothrombotic events  a marker for vulnerable blood. Arterioscler Thromb Vasc Biol, 2007; 27: 255-256","DOI":"10.1161\/01.ATV.0000252064.97632.2c"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Katopodis JN, Kolodny L, Jy W, Horstman LL, De Marchena EJ, Tao JG, Haynes DH, Ahn YS: Platelet microparticles and calcium homeostasis in acute coronary ischemias. Am J Hematol, 1997; 54: 95-101","DOI":"10.1002\/(SICI)1096-8652(199702)54:2<95::AID-AJH1>3.0.CO;2-Z"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Serebruany VL, Malinin AI, Ziai W, Pokov AN, Bhatt DL, Alberts MJ, Hanley DF: Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in patients after recent ischemic stroke: for the plavix use for treatment of stroke (PLUTO-Stroke) trial. Stroke, 2005; 36: 2289-2292","DOI":"10.1161\/01.STR.0000181081.09262.e1"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Merten M, Pakala R, Thiagarajan P, Benedict CR: Platelet microparticles promote platelet interaction with subendothelial matrix in a glycoprotein IIb\/IIIa-dependent mechanism. Circulation, 1999; 99: 2577-2582","DOI":"10.1161\/01.CIR.99.19.2577"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Leroyer AS, Isobe H, Leseche G, Castier Y, Wassef M, Mallat Z, Binder BR, Tedgui A, Boulanger CM: Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. J Am Coll Cardiol, 2007; 49: 772-777","DOI":"10.1016\/j.jacc.2006.10.053"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Huo Y, Schober A, Forlow SB, Smith DF, Hyman MC, Jung S, Littman DR, Weber C, Ley K: Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med, 2003; 9: 61-67","DOI":"10.1038\/nm810"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Ozaki H, Hla T, Lee MJ: Sphingosine-1-phosphate signaling in endothelial activation. J Atheroscler Thromb, 2003; 10: 125-131","DOI":"10.5551\/jat.10.125"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Marutsuka K, Hatakeyama K, Yamashita A, Asada Y: Role of thrombogenic factors in the development of atherosclerosis. J Atheroscler Thromb, 2005; 12: 1-8","DOI":"10.5551\/jat.12.1"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Shoji T, Koyama H, Fukumoto S, Maeno T, Yokoyama H, Shinohara K, Emoto M, Shoji T, Inaba M, Noshizawa Y: Platelet-monocyte aggregates are independently associated with occurrence of carotid plaques in type 2 diabetic patients. J Atheroscler Thromb, 2005; 12: 344-352","DOI":"10.5551\/jat.12.344"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Sato Y, Fujii S, Imagawa S, Ohmura K, Ohmura Y, Andoh Y, Dong J, Ishimori N, Furumoto T, Tsutsui H: Platelet aggregabolity in patients with hypertension treated with angiotensin II type 1 receptor blockers. J Atheroscler Thromb, 2007; 14: 31-35","DOI":"10.5551\/jat.14.31"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Nomura S, Takahashi N, Inami N, Kajiura T, Yamada K, Nakamori H, Tsuda N: Probucol and ticlopidine: Effect on platelet and monocyte activation markers in hyperlipidemic patients with and without type 2 diabetes. Atherosclerosis, 2004; 174: 329-335","DOI":"10.1016\/j.atherosclerosis.2004.01.027"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Nomura S, Tandon NN, Nakamura T, Cone J, Fukuhara S, Kambayashi J: High-shear-stress-induced activation of platelets and microparticles enhances expression of cell adhesion molecules in THP-1 and endothelial cells. Atherosclerosis, 2001; 158: 277-287","DOI":"10.1016\/S0021-9150(01)00433-6"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Tan KT, Lip GY: The potential role of platelet microparticles in atherosclerosis. Thromb Haemost, 2005; 94: 488-492","DOI":"10.1160\/TH05-03-0201"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Mause SF, von Hundelschausen P, Zernecke A, Koenen RR, Weber C: Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arterioscler Thromb Vasc Biol, 2005; 25: 1512-1518","DOI":"10.1161\/01.ATV.0000170133.43608.37"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Nomura S, Shouzu A, Omoto S, Inami N, Ueba T, Urase F, Maeda Y: Effects of eicosapentaenoic acid on endothelial cell-derived microparticles, angiopoietins and adiponectin in patients with type 2 diabetes. J Atheroscler Thromb, 2009; 16: 83-90","DOI":"10.5551\/jat.E091"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Nomura S, Inami N, Shouzu A, Urase F, Maeda Y: Correlation and association between plasma platelet-, monocyte- and endothelial cell-derived microparticles in hypertensive patients with type 2 diabetes mellitus. Platelets, 2009; 3 :1-9","DOI":"10.1080\/09537100903114545"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Morel O, Morel N, Freyssinet JM, Toti F: Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses. Platelets, 2008; 19: 9-23","DOI":"10.1080\/09537100701817232"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Burnier L, Fontana P, Kwak BR, Angelillo-Scherrer A: Cell-derived microparticles in haemostasis and vascular medicine. Thromb Haemost, 2009; 101: 439-451","DOI":"10.1160\/TH08-08-0521"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/16\/6\/16_2642\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T18:44:28Z","timestamp":1621536268000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/16\/6\/16_2642\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.2642","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009]]}}}